Jessica M. Jacobs
Associate, Research & Licensing @ Partners Innovation Fund
Boston, United States
Jessica M. Jacobs is a startup investor at Partners Innovation Fund in Boston. Jessica is responsible for negotiating, drafting, and providing legal support for research and licensing agreements for a variety of disciplines across BWH and MGH. In addition to her transactional work, Jessica supervises and mentors TAG’s law school interns and assists with orientation of new employees. Jessica formerly served as theAssistant Director of Dana Farber-Cancer Institute’s Office for the Protection of Research Subjects ("OPRS”) where she managed daily operations and provided regulatory guidance to investigators, the Institutional Review Board and the Animal Care and Use Committee. Jessica was awarded a Partners in Excellence Award for her work on behalf of the OPRS. While earning her law degree, Jessica interned with the U.S. Attorney’s Office Health Care Fraud Division in Boston, Boston University’s Office of Research Compliance and Health Information Privacy, and the CareGroup, Inc. General Counsel’s Office where she provided legal support for Beth Israel Deaconess Medical Center and several other hospitals and physician practices within the CareGroup network.
Last updated:
For AI agents: llms.txt
About Partners Innovation Fund
The Innovation Fund was created in 2007 by Brigham and Women's Hospital and Massachusetts General Hospital to address a growing unmet need for funding emerging technology in the capital gap between invention and product development.The main objective of the fund is to accelerate to market technologies developed by Partners HealthCareinvestigators, thereby enhancing healthcare quality, cost and outcomes. Structured as a separate LLC entity, the $35M Fund is evergreen in design and will reinvest all gains from investments back into the Fund to create capital for additional investments.Investment decision oversight is provided by an independent external committee composed of experts from industry, venture capital and academia.The Fund operates on a venture capital model whereby opportunities are rigorously evaluated on the basis of scientific strength as well as potential for commercial success.The Fund has four major goals:* Capture more value from the PHS research portfolio by creating companies, technologies and solutions that advance and enhance healthcare.* Provide funding for technologies positioned in the capital gap between invention and clinical development.* By demonstrating institutional commitment, attract external capital that will leverage and encourage co-investment.* Generate a return on investment to refresh the fund and provide capital for additional technologies.Gap FundingOver the last five to seven years, the environment for early-stage investing has undergone significant change. As a result of these changes, there is a dearth of funding support for technologies/companies positioned between invention and clinical development. By focusing on this capital gap, the Fund can advance technologies of high commercial potential and medical benefit to a stage where larger, more traditional investment sources are attracted to underwrite the risk.Types of Fund InvestmentsThe Partners Innovation Fund will make two types of investments: Equity and Development.Equity investments are seed and early financings that will catalyze company formation. These investments will often be a Series A stock and co-investors are frequently other early institutional investors, private investors or corporate investment funds.Development investments precede company formation and are intended to validate technologies with a high potential for later commercialization by either new venture formation or out-licensing to an existing market player.For all investments, funds will be reserved for participation in follow-on investments.Innovation Fund ProcessUtilizing a proven venture capital based diligence model, the team conducts in-depth diligence on all opportunities in two steps:1. Initial Screening: Assesses opportunities for high commercial potential. Key project attributes are:* Product concept and value proposition* Intellectual Property Position* Stage of technology development* Market Opportunity* Technology Review* Management Team* Regulatory pathway* Funding requirements* Competitive Analysis* Business Model 2. Evaluation and Investment Decision: During this step, PIF staff conducts extensive diligence to assess the strength of the proposed business in relation to our investment criteria. This process takes place over 3 to 6 months during which time we interact with technical and market experts, possible customers, competitors and potential co-investors as we prepare for presentation of the investment opportunity to our external Investment Committee for final approval.The team will work with investigators and their advisors to develop a project or business plan including connections to potential entrepreneurs, advisors and investors in the venture, private or corporate arena.Venture Launch / Ongoing Support: Once an investment has been approved, the Innovation Fund plays an active role in the ongoing development of the new venture. The team will work on all aspects required to move the new entity forward including recruiting senior management and staff, providing guidance and support in technology development, serving on the Board of Directors and working with management to achieve milestones.
Partners Innovation Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anne C. Pareti
Associate II
|
|||
Ellen Jung
Associate II
|
|||
|
Jessica M. Jacobs
Associate, Research & Licensing
|
|||
Michael Band
Manager, Business Development
|
|||
|
Pamela Keddy
Executive Assistant
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
